ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
61,644.65
4.27%
S&P 500
5,107.27
0.85%
Dow Jones
38,545.04
0.84%
US Dollar vs Yen
153.0355
-0.01%
Brent Oil
83.225
-0.48%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Addex Therapeutics Ltd (ADXN)

  7. Addex Therapeutics Ltd (ADXN) ニュース

ADXN Addex Therapeutics Ltd

9.25
0.40 (4.52%)
最終更新日： 23:42:18
15分遅延
名称 銘柄コード 市場 種別
Addex Therapeutics Ltd ADXN NASDAQ Depository Receipt
  前日比 前日比 % 現在値 時刻
Upgrade Icon
0.40 4.52% 9.25 23:42:18
始値 安値 高値 終値 前日終値
9.09 9.00 9.394 8.85
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2914:00GLOBEAddex Provides Update on ADX71149 Phase 2 Epilepsy Study
2024/4/1914:00GLOBEAddex to Present at the Swiss Biotech Day 2024
2024/4/1814:00GLOBEAddex Therapeutics Reports Full Year 2023 Financial Results..
2024/4/1114:00GLOBEAddex Therapeutics to Release Full-Year 2023 Financial..
2024/4/0314:00GLOBEAddex and Perceptive Launch Neurosterix with $63 Million to..
2024/3/1415:00GLOBEAddex to Present at the Bio-Europe Spring 2024 Conference
2024/1/3115:00GLOBEAddex Enters into At-The-Market ADS Offering Agreement with..
2024/1/3107:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/1/3106:58EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/0915:00GLOBEAddex to Present at the Swiss Equities Baader Conference
2024/1/0515:30GLOBEAddex to Present at Biotech Showcase™ 2024
2023/12/2120:00EDGAR2Form 6-K/A - Report of foreign issuer [Rules 13a-16 and..
2023/12/2020:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/2015:00GLOBEAddex Shareholders Approve All Resolutions at Extraordinary..
2023/12/1420:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/1415:00GLOBEAddex Creates Treasury Shares
2023/12/0904:11EDGAR2Form SC 13D/A - General statement of acquisition of..
2023/12/0106:00EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/11/3014:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/11/3006:00EDGAR2Form SC 13D/A - General statement of acquisition of..
2023/11/2920:27EDGAR2Form POS AM - Post-Effective amendments for registration..
2023/11/2920:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/2915:00GLOBEAddex Reports Q3 2023 Financial Results and Provides..
2023/11/2820:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/2815:00GLOBEAddex Convenes Extraordinary General Meeting
2023/11/2315:00GLOBEAddex Therapeutics to Release Third Quarter 2023 Financial..
2023/11/1415:00GLOBEAddex ADX71149 Epilepsy Phase 2 Study Completes Recruitment..
2023/11/0820:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/0815:00GLOBEAddex Regains Nasdaq Listing Compliance
2023/11/0215:00GLOBEAddex Announces Participation in the Bio-Europe 2023..
2023/10/2319:01EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/10/2019:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/2014:00GLOBEAddex Completes ADS Ratio Change
2023/10/0705:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/0705:00GLOBEAddex Announces Plan to Implement ADS Ratio Change
2023/9/2019:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/2014:00GLOBEAddex mGlu2 NAM Cognition Program Receives €4 Million Grant
2023/9/0614:00GLOBEAddex Announces Participation in the H.C. Wainwright 25th..
2023/9/0519:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/0519:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/0514:00GLOBEAddex ADX71149 Phase 2 Epilepsy Study Expected to Readout..
2023/9/0414:00GLOBEAddex’s Dipraglurant Development in Post-Stroke Recovery..
2023/8/1205:00EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/8/1105:00EDGAR2Form POS AM - Post-Effective amendments for registration..
2023/8/1019:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/8/1014:00GLOBEAddex Reports 2023 Half Year and Second Quarter Financial..
2023/8/0414:00GLOBEAddex Therapeutics to Release Half-Year 2023 Financial..
2023/8/0319:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/8/0314:00GLOBEAddex GABAB Positive Allosteric Modulator Program to Receive..
2023/7/2419:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

最近閲覧した銘柄

NASDAQ
ADXN
Addex Therapeutics
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有